Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials
- PMID:15504381
- DOI: 10.1016/j.contraception.2004.05.008
Effectiveness of the male latex condom: combined results for three popular condom brands used as controls in randomized clinical trials
Abstract
Background: Although public health programs invest heavily in the male latex condom, its efficacy in preventing pregnancy and sexually transmitted disease has been based primarily on in vitro and retrospective studies.
Methods: We combine the results from two randomized, controlled contraceptive efficacy trials that used commercial latex condoms brands (Ramses Sensitol, LifeStyles, Trojan-Enz) in the control arms. Combining data from the two studies, we obtained longitudinal data covering 3526 menstrual cycles contributed by approximately 800 couples who used latex condoms exclusively for up to six menstrual cycles. Both trials also collected 3715 detailed breakage and slippage reports from the first five study condom uses. The second trial also tested 243 postcoital vaginal samples collected after the first study condom use for the presence of prostate-specific antigen (PSA) and spermatazoa.
Results: The combined clinical breakage rate for the first five condom uses was 0.4% for the three latex brands and the combined clinical slippage rate was 1.1%. The combined six-cycle typical-use pregnancy rate for the latex condoms was 7.0% (95% confidence interval 5.0-9.0). The combined six-cycle consistent-use pregnancy rate was 1.0% (95% confidence interval 0.0-2.1). PSA was detected in only 1.2% of postcoital vaginal samples collected after the first use of an intact study condom. There were no differences in performance or efficacy among the three latex brands tested.
Conclusions: The male latex condoms rarely broke or slipped off during intercourse and provided high contraceptive efficacy, especially when used consistently. Risk of semen leakage from intact condoms was very low.
Similar articles
- Evaluation of the efficacy of a polyurethane condom: results from a randomized, controlled clinical trial.Frezieres RG, Walsh TL, Nelson AL, Clark VA, Coulson AH.Frezieres RG, et al.Fam Plann Perspect. 1999 Mar-Apr;31(2):81-7.Fam Plann Perspect. 1999.PMID:10224546Clinical Trial.
- Evaluation of the efficacy of a nonlatex condom: results from a randomized, controlled clinical trial.Walsh TL, Frezieres RG, Peacock K, Nelson AL, Clark VA, Bernstein L.Walsh TL, et al.Perspect Sex Reprod Health. 2003 Mar-Apr;35(2):79-86.Perspect Sex Reprod Health. 2003.PMID:12729137Clinical Trial.
- Breakage and acceptability of a polyurethane condom: a randomized, controlled study.Frezieres RG, Walsh TL, Nelson AL, Clark VA, Coulson AH.Frezieres RG, et al.Fam Plann Perspect. 1998 Mar-Apr;30(2):73-8.Fam Plann Perspect. 1998.PMID:9561872Clinical Trial.
- Comparative contraceptive efficacy of the female condom and other barrier methods.Trussell J, Sturgen K, Strickler J, Dominik R.Trussell J, et al.Fam Plann Perspect. 1994 Mar-Apr;26(2):66-72.Fam Plann Perspect. 1994.PMID:8033980Review.
- Non-latex versus latex male condoms for contraception.Gallo MF, Grimes DA, Schulz KF.Gallo MF, et al.Cochrane Database Syst Rev. 2003;(2):CD003550. doi: 10.1002/14651858.CD003550.Cochrane Database Syst Rev. 2003.Update in:Cochrane Database Syst Rev. 2006 Jan 25;(1):CD003550. doi: 10.1002/14651858.CD003550.pub2.PMID:12804475Updated.Review.
Cited by
- Objective non-intrusive markers of sperm production and sexual activity.Sivananthan T, Bathur F, Jimenez M, Conway A, Idan A, Handelsman D.Sivananthan T, et al.Asian J Androl. 2012 May;14(3):476-80. doi: 10.1038/aja.2012.2. Epub 2012 Apr 23.Asian J Androl. 2012.PMID:22522506Free PMC article.
- Time for the US food and drug administration approval of condoms for anal intercourse.Nguyen BT, Nelson AL.Nguyen BT, et al.EClinicalMedicine. 2019 Dec 12;17:100226. doi: 10.1016/j.eclinm.2019.11.019. eCollection 2019 Dec.EClinicalMedicine. 2019.PMID:31891150Free PMC article.No abstract available.
- The use of biomarkers of semen exposure in sexual and reproductive health studies.Snead MC, Black CM, Kourtis AP.Snead MC, et al.J Womens Health (Larchmt). 2014 Oct;23(10):787-91. doi: 10.1089/jwh.2014.5018. Epub 2014 Sep 30.J Womens Health (Larchmt). 2014.PMID:25268551Free PMC article.
- Assessment of the vaginal residence time of biomarkers of semen exposure.Thurman A, Jacot T, Melendez J, Kimble T, Snead M, Jamshidi R, Wheeless A, Archer DF, Doncel GF, Mauck C.Thurman A, et al.Contraception. 2016 Nov;94(5):512-520. doi: 10.1016/j.contraception.2016.05.012. Epub 2016 May 31.Contraception. 2016.PMID:27259675Free PMC article.Clinical Trial.
- Efficacy of a combined contraceptive regimen consisting of condoms and emergency contraception pills.Zhao R, Wu JQ, Li YY, Zhou Y, Ji HL, Li YR.Zhao R, et al.BMC Public Health. 2014 Apr 14;14:354. doi: 10.1186/1471-2458-14-354.BMC Public Health. 2014.PMID:24725355Free PMC article.Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous